Neuropeptidases responsables de l'inactivation des enképhalines et pharmacologie de leurs inhibiteurs.
J.C. Schwartz, Jeanne‐Marie Lecomte(Bioprojet (France)), Marie-Louise Bouthenet(Université Paris Cité), Sophie De La Baume, Claude P. Gros(Inserm), Catherine Llorens‐Cortés(Centre National de la Recherche Scientifique), H. Pollard(Inserm), N. Salès, Bruno Giros(Centre National de la Recherche Scientifique), Jean Costentin(Centre National de la Recherche Scientifique), Brigitte Solhonne
Journal de pharmacologie
January 1, 1986
Cited by 6
Related Papers
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
|Nature|1990|2.6k
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
|Nature|1996|2.5k
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
|Nature Genetics|2003|1.8k
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA
|Brain Research|1991|865
Profound neuronal plasticity in response to inactivation of the dopamine transporter
|Proceedings of the National Academy of Sciences|1998|724